Literature DB >> 15026783

Glycerol kinase deficiency: residual activity explained by reduced transcription and enzyme conformation.

Damayanti R Sjarif1, Christina Hellerud, Johannes K Ploos van Amstel, Willem J Kleijer, Wolfgang Sperl, Didier Lacombe, Jõrn Oliver Sass, Frits A Beemer, Marinus Duran, Bwee Tien Poll-The.   

Abstract

Four unrelated patients with glyceroluria ranging from 7 to 170 mmol/l were studied. The activity of glycerol kinase (GK) in cultured fibroblasts was determined with a specific enzyme assay and with two indirect methods, that is, incorporation into macromolecules of [(14)C] from [(14)C]glycerol and its oxidation to [(14)C]CO(2). Exon amplification and RT-PCR were used to identify mutations. In patient 1, with low activity in all three assays, we identified a c.1194A>C (E398D) missense mutation. In patient 2 with a considerable activity of the GK enzyme (22% of reference), oxidation to [(14)C]CO(2) (37%) and a high incorporation of [(14)C] into macromolecules (92%), we identified a c.182T>C (L61P) mutation that causes the enzyme to have a higher K(m) for glycerol ( approximately 300 microM) than normals (2-8 microM). In patient 3, the GK activity estimated by the three different methods ranged from 16 to 22% of reference. Analysis of mRNA from the GK gene revealed three alternatively spliced transcripts. A mutation in intron 3 (g.16835G>A) resulted in an insertion of a cryptic exon between exon 2 or 3 and exon 4. Patient 4 with minor glyceroluria (7 mmol/l) and normal plasma glycerol concentration had normal activity with all three assay methods, thus excluding GK deficiency (GKD) as a cause of slight glyceroluria. To evaluate fully patients with glyceroluria, one needs to measure the GK activity and relate this and the clinical data to genetic findings. Residual enzyme activities in cultured fibroblasts can be found in GKD patients with severe clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026783     DOI: 10.1038/sj.ejhg.5201172

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  5 in total

1.  β-Thalassemia Patients Revealed a Significant Change of Untargeted Metabolites in Comparison to Healthy Individuals.

Authors:  Syed Ghulam Musharraf; Ayesha Iqbal; Saqib Hussain Ansari; Sadia Parveen; Ishtiaq Ahmad Khan; Amna Jabbar Siddiqui
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

2.  Reflection of treatment proficiency of hydroxyurea treated β-thalassemia serum samples through nuclear magnetic resonance based metabonomics.

Authors:  Ayesha Khalid; Amna Jabbar Siddiqui; Saqib Hussain Ansari; Syed Ghulam Musharraf
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

3.  A rare co-occurrence of duchenne muscular dystrophy, congenital adrenal hypoplasia and glycerol kinase deficiency due to Xp21 contiguous gene deletion syndrome: case report.

Authors:  Asanka Rathnasiri; Udara Senarathne; Visvalingam Arunath; Thabitha Hoole; Ishara Kumarasiri; Oshanie Muthukumarana; Eresha Jasinge; Sachith Mettananda
Journal:  BMC Endocr Disord       Date:  2021-10-24       Impact factor: 2.763

4.  Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.

Authors:  Niall P Keegan; Steve D Wilton; Sue Fletcher
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.772

5.  Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenita.

Authors:  M G Shaikh; L Boyes; H Kingston; R Collins; G T N Besley; B Padmakumar; O Ismayl; I Hughes; C M Hall; C Hellerud; J C Achermann; P E Clayton
Journal:  J Med Genet       Date:  2008-09       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.